References
- Ribas D, Torre L, Fernández-Cid A. Multifocalidad tumoral de la mama y metástasis. In: Fernández-Cid A et al. Patologiá mamaria. Barcelona (Spain): Salvat Editores, SA, 1982; 513–21.
- Zanon G, Marquez M, Casanova L, Guis B, Lejarcegui JA. Cáncer de mama. In: González Merlo J et al. Oncología Ginecológica. Barcelona (Spain): Salvat Editores, SA, 1991; 379–542.
- Stegner AE. Patología de las enfermedades malignas de la mama. In: Strömberg J, Rosato FE. Cirugía de la mama. Barcelona (Spain): Salvat, SA, 1990; 68–101.
- Contesso G, Bertin F, Mathieu MC, Terrier P. Anatomie pathologique des cancers mammaires. Editions Techniques-Encycl. Méd. Chir (Paris-France), Gynécologie, 865 B10, 1991; 1–17.
- Weingold AB, Boltuch SM. Extragenital metastases to the uterus. Am J Obstet Gynecol 1961; 82: 1267–71.
- Mazur MT, Hsueh S, Gerseli DJ. Metastases to the female genital tract: analysis of 325 cases. Cancer 1984; 53: 1978–84.
- Taxi JB, Trujillo YP Breast cancer metastatic to the uterus. Clinical manifestations of a rare event. Arch Pathol Lab Med 1994; 118: 819–21.
- Le Bouëdec G, Kauffmann Ph, de Latour M et al. Métastases utérines des cancers du sein. A propos de 8 observations. J Gynecol Obstet Biol Reprod 1991; 20: 349–54.
- Clarke MR. Uterine malignant mixed mülleriane tumor in a patient on longterm tamoxifen therapy for breast cancer. Gynecol Oncol 1993; 51: 414–15.
- Jordan VC, Assikis VJ. Endometrial carcinoma and Tamoxifen: Clearing up a controversy. Clín Cancer Res 1995; 1: 467–72.
- Hardell L. Tamoxifen as risk factor for carcinoma of corpus uteri. Lancet 1988; 2: 563–6.
- Van Leeuwen FE, Benraat J, Coebergh JW et al. Risk endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994; 343(1): 448–52.
- Fornander T, Cedermark B, Mattson A et al. Adjuvant tamoxifen in early breast cancer. Occurrence of new primary cancers. Lancet 1989; l: 117–19.
- Gonzalez Merlo J, Lejarcegui JA, Casanova L et al. Adenocarcinoma de endometrio. In: González Merio J. Oncología Ginecológica. Barcelona: Salvat Editores, 1991; 211–61.
- Carrato A, Baron JM, Díaz N, Gonzalvez ML. Carcinoma uterino en el contexto de un cáncer de mama bilateral met-acrónico tratado con tamoxifeno durante tres años. ¿Primario o metastásico?. In: Miguel Martín. Cáncer de mama. Barcelona (Spain): Edika Med, 1995; 22–5.
- Stemmermann GN. Extrapelvic carcinoma metastatic to the uterus. Am J Obstet Gynecol 1961; 82: 1261–6.
- Harris M, Howell A, Chrissohou M, Swindell R, Hudson M, Sellwood RA. A comparison of metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 1984; 50: 23–30.
- Martínez l, Domínguez F et al. Cáncer de mama, tamoxifeno y patología endometrial. Rev Senología y Patol Mam 1990; 3: 175–8.
- Adami H, Krusemo UB, Berkgvist L. On the age-dependent between cancer of the breast and the endometrium. A nationwide cohort study. Br J Cancer 1987; 55: 77–80.
- Martínez-Montero I, Domínguez-Cunchillos F. Gynecologist’s importance in the Breast Unit. Rev Senologia y Patol Mam 1996; 9: 167–72.
References
- Johansen K. Pregnancy in a rudimentary horn, two case reports. Obstet Gynecol 1969; 34: 805–8.
- O’Grady JP, Salem FA. Rudimentary horn pregnancy with neonatal and fetal survival. J Natl Med Assoc 1978; 70: 863–6.
- Zaidi J, Carr J. Rupture of pregnant rudimentary uterine horn with fetal salvage. Acta Obstet Gynecol Scand 1994; 73: 359–60.
- Kriplani A, Relan S, Mittal S, Buckshee K. Pre-rupture diagnosis and management of rudimentary horn pregnancy in the first trimester. Eur J Obstet Reprod Biol 1995; 58: 203–5.
- Dulemba J, Midgett W, Freeman M. Laparoscopic management of a rudimentary horn pregnancy. J Am Assoc Gynecol Laparosc 1996; 3: 627–30.
- Chang JC, Lin YC. Rupture of rudimentary horn pregnancy. Acta Obstet Gynecol Scand 1992; 71: 235–8.